Cellosaurus cell line PD-1.3 (CVCL

Cellosaurus PD-1.3 (CVCL_DF55)

Cross-references
Cell line name	PD-1.3
Synonyms	PD1.3; PD1.3.1; PD1 3.1
Accession	CVCL_DF55
Resource Identification Initiative	To cite this cell line use: PD-1.3 (RRID:CVCL_DF55)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122. Monoclonal antibody isotype: IgG2b. Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_4032 (P3X63Ag8.653)
Category	Hybridoma
Publications	PubMed=20587542; DOI=10.1093/intimm/dxq049; PMCID=PMC3168865 Marguerite Ghiotto, Laurent Gauthier, Nacer-Eddine Serriari, Sonia Pastor, Alemseged Truneh, Jacques A. Nunes, Daniel Olive; PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int. Immunol. 22:651-660(2010) PubMed=20693422; DOI=10.4049/jimmunol.0902487 Nacer-Eddine Serriari, Francoise Gondois-Rey, Yves Guillaume, Ester B.M. Remmerswaal, Sonia Pastor, Nassima Messal, Alemseged Truneh, Ivan Hirsch, Rene A.W. van Lier, Daniel Olive; B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185:3140-3148(2010) Patent=US9637546 Daniel Olive, Nacer-Eddine Serriari, Jacques A. Nunes, Marguerite Ghiotto; PD-1 antibodies and PD-L1 antibodies and uses thereof. Patent number US9637546, 02-May-2017 Patent=US9896507 Daniel Olive, Francoise Gondois-Rey, Nacer-Eddine Serriari, Sonia Pastor; BTLA antibodies and uses thereof. Patent number US9896507, 20-Feb-2018 Patent=US10005839 Daniel Olive, Christine Pasero, Julie Gertner-Dardenne; Antagonist of the BTLA/HVEM interaction for use in therapy. Patent number US10005839, 26-Jun-2018
Encyclopedic resources	Wikidata; Q54946766
Entry history
Entry creation	13-Jul-2016
Last entry update	21-Mar-2023
Version number	8